Renal Cell Carcinoma
JAMA Clinical Reviews
Advancements in Stage 4 Metastatic Kidney Cancer Treatment
This chapter explores the transition from ineffective chemotherapy to targeted therapies and immunotherapy for patients with stage 4 metastatic kidney cancer. It highlights the significance of personalized treatment approaches based on molecular characteristics and patient prognosis for improved long-term survival outcomes.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
